Menlo Therapeutics Inc. (42) | Business Finance (13)

Browse by Subcategory

Recent Contracts

Registration Rights Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park (Filed With SEC on March 15, 2022)
Purchase Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park (Filed With SEC on March 15, 2022)
Amendment No. 1 to Amended and Restated Credit Agreement and Guaranty, dated August 5, 2020, by and among Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., Foamix... (Filed With SEC on August 6, 2020)
Underwriting Agreement, dated June 4, 2020, among Menlo Therapeutics Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named in... (Filed With SEC on June 9, 2020)
Menlo Therapeutics Inc. 2019 Employee Share Purchase Plan (Filed With SEC on May 11, 2020)
Form of Warrant, by and among Menlo Therapeutics Inc. and certain warrant holders of Foamix Pharmaceuticals Ltd (Filed With SEC on March 10, 2020)
Contingent Stock Rights Agreement, dated as of March 9, 2020, by and between Menlo Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on March 10, 2020)
Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation (Filed With SEC on January 13, 2022)
Form of Securities Purchase Agreement, dated January 26, 2021, among VYNE Therapeutics Inc. and the purchasers identified therein (Filed With SEC on January 28, 2021)
Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Perceptive Credit Holdings II, LP (Filed With SEC on May 11, 2020)
Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Orbimed Royalty & Credit Opportunities III, LP (Filed With SEC on May 11, 2020)
Amended and Restated Credit Agreement and Guaranty, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., the... (Filed With SEC on May 11, 2020)
Amended and Restated Security Agreement, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. and Perceptive Credit... (Filed With SEC on May 11, 2020)